Targets and self management for the control of blood pressure in stroke and other at-risk groups (TASMIN-SR): a randomised controlled trial

Conditions

Topic: Primary Care Research Network for England, Cardiovascular

Kate Fletcher, Jonathan Mant, Richard J. McManus, Richard Hobbs

Programme Grants for Applied Research2016-03-013 citations

Effect of Self-monitoring and Medication Self-titration on Systolic Blood Pressure in Hypertensive Patients at High Risk of Cardiovascular Disease

Richard J. McManus, Jonathan Mant, Sayeed Haque, Emma P Bray, Stirling Bryan et al. (16 authors)

JAMA2014-08-26394 citations

10.1001/jama.2014.10057

Success with Self-monitoring: Results from the TASMIN-SR Trial

M. Cunningham, Richard J. McManus

MD Conference Express2013-07-01

10.1177/155989771309009

Targets and self-management for the control of blood pressure in stroke and at risk groups (TASMIN-SR): protocol for a randomised controlled trial.

O'Brien C, Bray EP, Bryan S, Greenfield SM, Haque MS, Hobbs FD, Jones MI, Jowett S, Kaambwa B, Little P, Mant J, Penaloza C, Schwartz C, Shackleford H, Varghese J, Williams B, McManus RJ.

2013-03-2314 citations

10.1186/1471-2261-13-21

Interventions

Self management of BP: Patients will monitor their own blood pressure at home each month, and follow a pre-determined titration plan if their BP is above target over two consecutive months. Follow-up

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged above 35 years, either sex 2. Have had a diagnosis of stroke/TIA, diabetes, CKD3, MI, angina, or CABG 3. Systolic blood pressure greater than 130/80 mmHg

Exclusion criteria

Exclusion criteria: 1. Inability to self-monitor such as dementia or score over 10 on the short orientation memory concentration test (and with no carer support) 2. Postural hypotension (fall in SBP greater than 20 mmHg after 1 minute standing) 3. Taking more than three anti-hypertensive medications 4. Taking part in a current blood pressure study or previously taken part in TASMINH2 5. Terminal disease 5. Pregnant 6. Blood pressure not managed by the GP and acute cardiovascular event in the last 3 months

Design outcomes

Primary

Measure	Time frame
Systolic blood pressure, measured at baseline, 6 months and 12 months	—

Secondary

Measure	Time frame
1. Adverse events, measured at baseline, 6 months and 12 months 2. Anxiety, measured at baseline, 6 months and 12 months 3. Attitudes to health and health care, measured at baseline, 6 months and 12 months 4. Blood pressure measurement preference, measured at baseline, 6 months and 12 months 5. Diastolic Blood pressure, measured at baseline, 6 months and 12 months 6. Health related quality of life, measured at baseline, 6 months and 12 months 7. Lifestyle behaviours, measured monthly 8. Pulse rate, measured at baseline, 6 months and 12 months 9. Reasons for non-participation, measured at invitation/baseline 10. Self-care strategies, measured at baseline, 6 months and 12 months 11. Self-management self-efficacy, measured monthly 12. Time at target blood pressure, measured at baseline, 6 months and 12 months	—

Measure

Time frame

1. Adverse events, measured at baseline, 6 months and 12 months 2. Anxiety, measured at baseline, 6 months and 12 months 3. Attitudes to health and health care, measured at baseline, 6 months and 12 months 4. Blood pressure measurement preference, measured at baseline, 6 months and 12 months 5. Diastolic Blood pressure, measured at baseline, 6 months and 12 months 6. Health related quality of life, measured at baseline, 6 months and 12 months 7. Lifestyle behaviours, measured monthly 8. Pulse rate, measured at baseline, 6 months and 12 months 9. Reasons for non-participation, measured at invitation/baseline 10. Self-care strategies, measured at baseline, 6 months and 12 months 11. Self-management self-efficacy, measured monthly 12. Time at target blood pressure, measured at baseline, 6 months and 12 months

—

Countries

United Kingdom

Outcome results

None listed